These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8313319)

  • 1. Continuous-infusion cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Lynch TJ; Kalish LA; Kass F; Strauss G; Elias A; Skarin A; Shulman L; Sugarbaker D; Frei E
    Cancer; 1994 Feb; 73(4):1171-6. PubMed ID: 8313319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group B.
    Vokes EE; Lyss AP; Herndon JE; Cooper B; Perry MC; Vinciguerra V; Mason-Coughlin K; Green MR
    Ann Oncol; 1992 Nov; 3(9):727-32. PubMed ID: 1333267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of cisplatin, 5-fluorouracil, leucovorin, and etoposide in advanced non-small-cell lung cancer.
    Rixe O; Coeffic D; Orcel B; Maitre B; Borel C; Benhammouda A; Petit T; Khayat D; Derenne JP
    Am J Clin Oncol; 1997 Apr; 20(2):128-31. PubMed ID: 9124184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
    Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
    Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck.
    Dreyfuss AI; Clark JR; Wright JE; Norris CM; Busse PM; Lucarini JW; Fallon BG; Casey D; Andersen JW; Klein R
    Ann Intern Med; 1990 Feb; 112(3):167-72. PubMed ID: 2297193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
    Chi KH; Chan WK; Shu CH; Law CK; Chen SY; Yen SH; Chen KY
    Cancer; 1995 Dec; 76(11):2186-92. PubMed ID: 8635020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study of ambulatory infusional delivery of a multidrug regimen: cisplatin, 5-fluorouracil and leucovorin (PFL) +/- etoposide.
    Lokich J; Anderson N; Moore C; Bern M; Coco F; Dow E; Zipoli T; Gonzalves L
    J Infus Chemother; 1996; 6(1):43-6. PubMed ID: 8748007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
    Vokes EE; Moormeier JA; Ratain MJ; Egorin MJ; Haraf DJ; Mick R; Weichselbaum RR
    Cancer Chemother Pharmacol; 1992; 29(3):178-84. PubMed ID: 1733549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous-infusion cisplatin, 5-fluorouracil, and bolus methotrexate in the treatment of advanced non-small cell lung cancer.
    Lynch TJ; Clark JR; Kalish LA; Fallon BG; Elias AD; Skarin A; Frei E
    Cancer; 1992 Oct; 70(7):1880-5. PubMed ID: 1326396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent 5-fluorouracil, leucovorin, etoposide, cisplatin and radiotherapy for locally advanced non-small cell lung cancer.
    Yang CT; Chang WC; Chen LH; Leung WM; Lee CH; Liaw CC
    Changgeng Yi Xue Za Zhi; 1997 Sep; 20(3):187-94. PubMed ID: 9397609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
    Vokes EE; Schilsky RL; Weichselbaum RR; Guaspari A; Guarnieri CM; Whaling SM; Panje WR
    Cancer; 1989 Mar; 63(6 Suppl):1048-53. PubMed ID: 2783881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach.
    Vokes EE; Haraf DJ; McEvilly JM; Mick R; Kozloff MF; Goldman MD; Moran WJ; Clendeninn NJ; Collier MA; Weichselbaum RR
    Ann Oncol; 1992 Jan; 3(1):79-81. PubMed ID: 1606074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
    Pujol JL; Lafontaine T; Quantin X; Reme-Saumon M; Cupissol D; Khial F; Michel FB
    Chest; 1999 Jan; 115(1):144-50. PubMed ID: 9925076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
    Ajlouni M; Chapman R; Kim JH
    Cancer J Sci Am; 1996; 2(6):314-20. PubMed ID: 9166551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer.
    Pfister DG; Bajorin D; Motzer R; Scher H; Louison C; Harrison L; Shah J; Strong E; Bosl G
    Arch Otolaryngol Head Neck Surg; 1994 Jan; 120(1):89-95. PubMed ID: 8274261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma.
    Chi KH; Chan WK; Cooper DL; Yen SH; Lin CZ; Chen KY
    Cancer; 1994 Jan; 73(2):247-52. PubMed ID: 8293384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer.
    Vokes EE; Vijayakumar S; Hoffman PC; Ferguson MK; Bitran JD; Krishnasamy S; Jacobs R; Golomb HM
    Cancer; 1990 Aug; 66(3):437-42. PubMed ID: 2163744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.